1. Gilead says remdesivir cut risk of COVID patient death in clinical trial — BioNTech-Pfizer COVID vaccine expected to be ready for approval by year end — LEO Pharma eyeing 2021 launch for Dupixent rival — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Conmed

Anonymous board for Conmed


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    0
    Views:
    117
  2. anonymous
    Replies:
    0
    Views:
    166
  3. anonymous
    Replies:
    235
    Views:
    31,754
  4. Anonymous
    Replies:
    92
    Views:
    35,167
  5. anonymous
    Replies:
    16
    Views:
    2,531
  6. anonymous
    Replies:
    7
    Views:
    973
  7. anonymous
    Replies:
    3
    Views:
    464
  8. anonymous
    Replies:
    47
    Views:
    13,355
  9. Anonymous
    Replies:
    58
    Views:
    10,345
  10. anonymous
    Replies:
    0
    Views:
    258
  11. anonymous
    Replies:
    53
    Views:
    3,581
  12. anonymous
    Replies:
    4
    Views:
    754
  13. anonymous
    Replies:
    8
    Views:
    749
  14. anonymous
    Replies:
    74
    Views:
    7,195
  15. anonymous
    Replies:
    68
    Views:
    16,606
  16. Conmed CEO
    Replies:
    55
    Views:
    14,464
  17. anonymous
    Replies:
    9
    Views:
    4,037
  18. anonymous
    Replies:
    64
    Views:
    11,819
  19. anonymous
    Replies:
    58
    Views:
    5,169
  20. anonymous
    Replies:
    0
    Views:
    540

Thread Display Options

Loading...